Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

2(40.0%)

Phase 2

2(40.0%)

N/A

1(20.0%)

5Total

Phase 3(2)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06577727Completed

A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children

Role: collaborator

NCT07091942Recruiting

Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Role: collaborator

NCT03785106Phase 3Active Not Recruiting

Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals

Role: collaborator

NCT01580865Not ApplicableCompleted

Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis

Role: collaborator

NCT01788891Completed

Second-line Therapy

Role: collaborator

NCT01307124Phase 3Completed

Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)

Role: collaborator

NCT01557478Phase 2Unknown

Melatonin as Adjuvant Therapy in Breast Cancer Patients

Role: collaborator

NCT01706627Phase 2Completed

Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial

Role: collaborator

All 8 trials loaded